Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Electrochemotherapy for Recurrent Vulvar Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating electrochemotherapy for recurrent vulvar cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Vulvar Cancer, Recurrent Vulvar Cancer | Phase 2 | Status: RECRUITING